Evidence map›Paper›PMID 39948483›Full record

ArticleBMC cancer2025

Effects of BMI on prognosis, disease-free survival and overall survival of breast cancer.

Vahid Zangouri, Souzan Soufizadeh Balaneji, Roya Golmoradi, Ehsan Kafili, Saleh Bologhi, Seyed Amin Mousavi, Ataollah Ahmadi Hesar, Morteza Amestejani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vahid ZangouriBreast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Souzan Soufizadeh BalanejiDepartment of Obstetrics and Gynecology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Roya GolmoradiBreast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ehsan KafiliBreast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Saleh BologhiBreast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Amin MousaviBreast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ataollah Ahmadi HesarBreast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Morteza AmestejaniDepartment of General Surgery, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran. m.amestejani@gmail.com.ORCID http://orcid.org/0000-0001-8851-8549

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObese breast cancer patients have worse prognosis than normal weight patients, but the level at which obesity is prognostically unfavorable is unclear. This study aimed to investigate different effects of Body Mass Index (BMI) on prognosis disease-free survival and overall survivor of breast cancer patients.

methodThis retrospective cohort study analyzed the medical records of breast cancer patients who sought treatment at Namazi hospital in Shiraz, Iran between 2014 and 2019. Three groups of patients were divided according to BMI. Menopausal status, BMI status, clinicopathological characteristics, treatment, and overall survival (OS), and disease free survival (DFS) were comprehensively evaluated. The World Health Organization (WHO) BMI classification was used to categorize patients into three groups: normal weight (BMI < 25.0 kg/m2), overweight (25.0 ≤ BMI < 30.0 kg/m2), and obese (BMI ≥ 30.0 kg/m2).

resultsOf the 7134 breast cancer patients, the majority (42.6%) were in 25-30 kg/m

conclusionObesity leads to worse DFS and OS in patients with BC and the effects of obesity on the breast cancer prognosis seem to be clinically related to menopausal status. Once validated, these results should be considered in the development of prevention programs.

Indexed as

Body Mass IndexBreast NeoplasmsObesityAdultAgedDisease-Free SurvivalFemaleHumansIranMenopauseMiddle AgedPrognosisRetrospective StudiesBody mass indexBreast cancerPrognosisSurvival

Identifiers

PMID39948483
PMCPMC11827321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.